Targeted CT‐guided punction of an intrapericardial abscess in HeartWare left ventricular patient. New diagnostic tool to highlight patients on the heart transplant waiting list

2019 ◽  
Vol 34 (11) ◽  
pp. 1361-1362
Author(s):  
Medhat Radwan ◽  
Petar Risteski ◽  
Anton Moritz ◽  
Aron‐Frederik Popov
Keyword(s):  
Heart Transplant ◽  
Diagnostic Tool ◽  
Left Ventricular ◽  
Waiting List ◽  
Ct Guided

scholarly journals Regaining Candidacy for Heart Transplantation after Robotic Assisted Laparoscopic Radical Prostatectomy in Left Ventricular Assist Device Patient

2012 ◽  
Vol 2012 ◽  
pp. 1-4 ◽  
Author(s):  
Tariq A. Khemees ◽  
Ahmad Shabsigh
Keyword(s):  
Prostate Cancer ◽  
Radical Prostatectomy ◽  
Heart Transplantation ◽  
Left Ventricular Assist Device ◽  
Heart Transplant ◽  
Left Ventricular ◽  
Waiting List ◽  
Assist Device ◽  
Ventricular Assist ◽  
Left Ventricular Assist

Several factors may highlight the relevance of prostate cancer to the pre-heart-transplant population. First, the expansion in candidate selection criteria led to increased number of men over the age of fifty to be considered for heart transplantation. With the introduction of left ventricular assist device (LVAD) therapy, waiting-list mortality has dramatically declined over the past decade. Additionally, transplant candidates are diligently screened for preexisting neoplasm while on the waiting list. Taken together, screening-detected prostate cancer may increasingly be diagnosed in patients on the waiting list. If discovered, it will pose unique challenge to clinicians as to date there has been no universally accepted management guideline. We report a case of LVAD-treated heart transplant candidate diagnosed with prostate cancer while on the waiting list. Patient screening demonstrated PSA elevation which prompted prostate biopsy. Low-risk clinically localized prostate cancer was confirmed and led to removal of patient from transplant list. When counseled regarding management of his cancer, the patient elected to undergo radical prostatectomy in a hope to regain candidacy for heart transplantation. Despite being of high surgical risk, multidisciplinary team approach led to successful management of prostate cancer and the patient eventually received heart transplant one year following prostatectomy.

Minimally Invasive Left Ventricular Assist Device Insertion Facilitates Subsequent Heart Transplant

2021 ◽  
pp. 155698452098040
Author(s):  
Joseph Rabin ◽  
Luke A. Ziegler ◽  
Sarah Cipriano ◽  
Ronson J. Madathil ◽  
Erika D. Feller ◽  
...  
Keyword(s):  
Minimally Invasive ◽  
Left Ventricular Assist Device ◽  
Heart Transplant ◽  
Ventricular Assist Device ◽  
Cardiac Transplantation ◽  
Left Ventricular ◽  
Assist Device ◽  
Ventricular Assist ◽  
Ischemic Time ◽  
Left Ventricular Assist

Objective We have observed that minimally invasive left ventricular assist device (LVAD) insertion leads to more facile re-entry and easier cardiac transplantation. We hypothesize minimally invasive LVAD implantation results in improved outcomes at the time of subsequent heart transplant. Methods All adults undergoing cardiac transplantation between October 2015 and March 2019 at our institution were retrospectively reviewed. Those bridged to transplantation with a HeartWare HVAD were identified and divided into 2 cohorts based upon the surgical approach: those who underwent HVAD placement by conventional sternotomy versus minimally invasive insertion via lateral thoracotomy and hemisternotomy (LTHS). Patient demographics, as well as perioperative transplant outcomes, including survival, length of stay (LOS), blood utilization, ischemic time, bypass time, and postoperative extracorporeal membrane oxygenation (ECMO) were compared between cohorts. Results Forty-two patients were bridged to heart transplant with a HVAD implanted via either sternotomy ( n = 22) or LTHS technique ( n = 20). Demographics were similar between groups. There was 1 predischarge death in the sternotomy group and none in the LTHS group. Body surface area, cardiopulmonary bypass time, ischemic time, ECMO utilization, and reoperation for bleeding were similar. Red blood cell units transfused were significantly lower in the LTHS cohort (3.0 [1.0-5.0] vs 6.0 [2.5-10.0] P = 0.046). The LTHS cohort had a significantly shorter hospital LOS (12.0 [11.0-28.0] vs 22.5 [15.7-41.7] P = 0.022) with a trend toward shorter intensive care unit LOS (6.0 [5.0-10.5] vs 11.0 [6.0-21.5] days P = 0.057). Conclusions Minimally invasive HVAD implantation improves outcomes at subsequent heart transplantation, resulting in shorter LOS and less red cell transfusion. Larger multi-institutional studies are necessary to validate these findings.

Psychiatric problems of heart transplant candidates with left ventricular assist devices

2006 ◽  
Vol 9 (4) ◽  
pp. 203-208 ◽  
Author(s):  
Atsushi Baba ◽  
Goichi Hirata ◽  
Fujio Yokoyama ◽  
Kyouichi Kenmoku ◽  
Miyoko Tsuchiya ◽  
...  
Keyword(s):  
Heart Transplant ◽  
Left Ventricular ◽  
Ventricular Assist Devices ◽  
Left Ventricular Assist Devices ◽  
Ventricular Assist ◽  
Assist Devices ◽  
Left Ventricular Assist ◽  
Transplant Candidates ◽  
Psychiatric Problems
Sign in / Sign up

Export Citation Format

Share Document